Form4insider filings, from the source

SEC Form 4 · accession 0001171843-15-003968

Sucampo Pharmaceuticals, Inc. · SCMP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jul 20, 2015
Accepted (ET)
Jul 22, 2015 · 4:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001365216

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Class A Common StockJul 20, 2015M45,000$14.82A45,000D
Class A Common StockF1Jul 20, 2015S45,000$23.43D0D
Class A Common StockJul 20, 2015M6,810$6.75A6,810D
Class A Common StockF1Jul 20, 2015S6,810$23.43D0D
Class A Common StockJul 20, 2015M12,718$6.75A12,718D
Class A Common StockF1Jul 20, 2015S12,718$23.43D0D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)$14.82Jul 20, 2015M45,000DMar 31, 2015Aug 31, 2015Class A Common Stock45,000235,650D
Employee Stock Option (right to buy)$6.75Jul 20, 2015M6,810DMar 31, 2015Aug 31, 2015Class A Common Stock6,810228,840D
Employee Stock Option (right to buy)$6.75Jul 20, 2015M12,718DMar 31, 2015Aug 31, 2015Class A Common Stock12,718216,122D

Explanation of responses